Oder Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
2,075
-41
-2% -$5.4K 0.18% 98
2026
Q1
$295K Buy
2,116
+1
+0% +$140 0.23% 86
2025
Q4
$260K Sell
2,115
-63
-3% -$7.66K 0.19% 91
2025
Q3
$241K Hold
2,178
0.17% 92
2025
Q2
$241K Buy
2,178
+1
+0% +$106 0.18% 94
2025
Q1
$244K Sell
2,177
-66
-3% -$6.81K 0.21% 88
2024
Q4
$207K Buy
+2,243
New +$202K 0.17% 90
2024
Q1
Sell
-2,847
Closed -$231K 91
2023
Q4
$231K Sell
2,847
-195
-6% -$15.2K 0.23% 84
2023
Q3
$228K Buy
3,042
+4
+0.1% +$308 0.25% 82
2023
Q2
$234K Sell
3,038
-64
-2% -$5.1K 0.26% 82
2023
Q1
$257K Buy
3,102
+135
+5% +$11.2K 0.3% 75
2022
Q4
$255K Buy
+2,967
New +$235K 0.32% 74
2022
Q2
Sell
-3,722
Closed -$221K 81
2022
Q1
$221K Sell
3,722
-302
-8% -$19.3K 0.25% 82
2021
Q4
$292K Buy
4,024
+532
+15% +$36.6K 0.41% 67
2021
Q3
$243K Buy
3,492
+3
+0.1% +$211 0.36% 71
2021
Q2
$240K Sell
3,489
-90
-3% -$6.01K 0.31% 75
2021
Q1
$231K Sell
3,579
-4,206
-54% -$271K 0.32% 75
2020
Q4
$457K Buy
+7,785
New +$470K 0.45% 55

Other funds holding GILD

Oder Investment Management's GILD Position: Q2 2026 in Review

Oder Investment Management reduced its Gilead Sciences (GILD) stake by 1.9% in Q2 2026, selling an estimated $5.4K and leaving 2,075 shares worth $262K. The position accounts for 0.18% of the portfolio, ranked #98.

Oder Investment Management first reported a position in GILD in Q4 2020 and has held it in 18 quarters since. The position peaked at $457K in Q4 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Oder Investment Management held 2,075 shares of Gilead Sciences worth $262K as of Q2 2026.
  • Oder Investment Management sold 41 Gilead Sciences shares in Q2 2026, an estimated $5.4K.
  • Gilead Sciences made up 0.18% of Oder Investment Management's portfolio in Q2 2026, its #98 holding.
  • Oder Investment Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 18 quarters since.
  • Oder Investment Management's Gilead Sciences position peaked at $457K in Q4 2020.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Oder Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.